B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Technetium

285 PubMed studies analyzed · 2 RCTs · Evidence Score: 44.8

Research Domains

Technetium has been studied across 14 research domains including ⏳ Longevity & Aging, 🔬 Oncology, 🧬 Hormones, ❤️ Cardiovascular, 🫘 Kidney. The primary research focus is ⏳ Longevity & Aging with 44% of studies addressing this area.

Loading evidence profile...

This evidence profile for Technetium is generated deterministically from 285 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.